Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48


Wnt and Kras signaling-dark siblings in lung cancer.

Pacheco-Pinedo EC, Morrisey EE.

Oncotarget. 2011 Jul;2(7):569-74.


MicroRNAs and lung cancer: from markers to targets.

Sozzi G, Pastorino U, Croce CM.

Cell Cycle. 2011 Jul 1;10(13):2045-6. No abstract available.


Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.

Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M, Vuerhard M, Buijs-Gladdines J, Kooi C, Klous P, van Vlierberghe P, Ferrando AA, Cayuela JM, Verhaaf B, Beverloo HB, Horstmann M, de Haas V, Wiekmeijer AS, Pike-Overzet K, Staal FJ, de Laat W, Soulier J, Sigaux F, Meijerink JP.

Cancer Cell. 2011 Apr 12;19(4):484-97. doi: 10.1016/j.ccr.2011.02.008.


Suppression of lung adenocarcinoma progression by Nkx2-1.

Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ, Whittaker CA, Hoersch S, Yoon S, Crowley D, Bronson RT, Chiang DY, Meyerson M, Jacks T.

Nature. 2011 May 5;473(7345):101-4. doi: 10.1038/nature09881. Epub 2011 Apr 6.


A precursor microRNA in a cancer cell nucleus: get me out of here!

Melo SA, Esteller M.

Cell Cycle. 2011 Mar 15;10(6):922-5. Epub 2011 Mar 15.


Both gene amplification and allelic loss occur at 14q13.3 in lung cancer.

Harris T, Pan Q, Sironi J, Lutz D, Tian J, Sapkar J, Perez-Soler R, Keller S, Locker J.

Clin Cancer Res. 2011 Feb 15;17(4):690-9. doi: 10.1158/1078-0432.CCR-10-1892. Epub 2010 Dec 10.


MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia.

Lizé M, Herr C, Klimke A, Bals R, Dobbelstein M.

Cell Cycle. 2010 Nov 15;9(22):4579-83. Epub 2010 Nov 15.


Comparison and integration of target prediction algorithms for microRNA studies.

Zhang Y, Verbeek FJ.

J Integr Bioinform. 2010 Mar 25;7(3). doi: 10.2390/biecoll-jib-2010-127.


Causes and consequences of microRNA dysregulation in cancer.

Croce CM.

Nat Rev Genet. 2009 Oct;10(10):704-14. doi: 10.1038/nrg2634. Review.


MicroRNA-127 modulates fetal lung development.

Bhaskaran M, Wang Y, Zhang H, Weng T, Baviskar P, Guo Y, Gou D, Liu L.

Physiol Genomics. 2009 May 13;37(3):268-78. doi: 10.1152/physiolgenomics.90268.2008. Epub 2009 Mar 17.


Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.

Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T, Miyazono K.

Cancer Res. 2009 Apr 1;69(7):2783-91. doi: 10.1158/0008-5472.CAN-08-3490. Epub 2009 Mar 17.


Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.

Hsu DS, Acharya CR, Balakumaran BS, Riedel RF, Kim MK, Stevenson M, Tuchman S, Mukherjee S, Barry W, Dressman HK, Nevins JR, Powers S, Mu D, Potti A.

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5312-7. doi: 10.1073/pnas.0900827106. Epub 2009 Mar 11. Erratum in: Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14705.


MicroRNAs: target recognition and regulatory functions.

Bartel DP.

Cell. 2009 Jan 23;136(2):215-33. doi: 10.1016/j.cell.2009.01.002. Review.


Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.

Anagnostou VK, Syrigos KN, Bepler G, Homer RJ, Rimm DL.

J Clin Oncol. 2009 Jan 10;27(2):271-8. doi: 10.1200/JCO.2008.17.0043. Epub 2008 Dec 8.


Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.

Barletta JA, Perner S, Iafrate AJ, Yeap BY, Weir BA, Johnson LA, Johnson BE, Meyerson M, Rubin MA, Travis WD, Loda M, Chirieac LR.

J Cell Mol Med. 2009 Aug;13(8B):1977-86. doi: 10.1111/j.1582-4934.2008.00594.x.


Most mammalian mRNAs are conserved targets of microRNAs.

Friedman RC, Farh KK, Burge CB, Bartel DP.

Genome Res. 2009 Jan;19(1):92-105. doi: 10.1101/gr.082701.108. Epub 2008 Oct 27.


TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.

Perner S, Wagner PL, Soltermann A, LaFargue C, Tischler V, Weir BA, Weder W, Meyerson M, Giordano TJ, Moch H, Rubin MA.

J Pathol. 2009 Jan;217(1):65-72. doi: 10.1002/path.2443.


MicroRNAs in cancer.

Lee YS, Dutta A.

Annu Rev Pathol. 2009;4:199-227. doi: 10.1146/annurev.pathol.4.110807.092222. Review.


MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries.

Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, Kroh EM, Bendoraite A, Mitchell PS, Nelson AM, Ruzzo WL, Ware C, Radich JP, Gentleman R, Ruohola-Baker H, Tewari M.

Stem Cells. 2008 Oct;26(10):2496-505. doi: 10.1634/stemcells.2008-0356. Epub 2008 Jun 26.


Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3903-8. doi: 10.1073/pnas.0712321105. Epub 2008 Feb 28.

Supplemental Content

Support Center